{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20191219",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "61348",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761064s009lbl.pdf",
              "date": "20191219",
              "type": "Label"
            },
            {
              "id": "61392",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761064Orig1s009ltr.pdf",
              "date": "20191223",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170622",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "48800",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761064s000lbl.pdf",
              "date": "20170622",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20200505",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "62835",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761064Orig1s008,s010ltr.pdf",
              "date": "20200506",
              "type": "Letter"
            },
            {
              "id": "62838",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761064s008s010lbl.pdf",
              "date": "20200506",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170622",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "48827",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761064Orig1s000ltr.pdf",
              "date": "20170626",
              "type": "Letter"
            },
            {
              "id": "55872",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/761064Orig1s000TOC.html",
              "date": "20181011",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20200505",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "62834",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761064Orig1s008,s010ltr.pdf",
              "date": "20200506",
              "type": "Letter"
            },
            {
              "id": "62839",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761064s008s010lbl.pdf",
              "date": "20200506",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20210610",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "67770",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf",
              "date": "20210611",
              "type": "Label"
            },
            {
              "id": "67771",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28",
              "date": "20210611",
              "type": "Medication Guide"
            },
            {
              "id": "67777",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761064Orig1s013ltr.pdf",
              "date": "20210614",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA761064",
      "sponsor_name": "GENENTECH INC",
      "openfda": {
        "application_number": [
          "BLA761064"
        ],
        "brand_name": [
          "RITUXAN HYCELA"
        ],
        "generic_name": [
          "RITUXIMAB AND HYALURONIDASE"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-108",
          "50242-109"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "HYALURONIDASE (HUMAN RECOMBINANT)",
          "RITUXIMAB"
        ],
        "rxcui": [
          "1927885",
          "1927890",
          "1927893",
          "1927894"
        ],
        "spl_id": [
          "e8a259ac-2a09-4026-823c-f23cbcba6a2b"
        ],
        "spl_set_id": [
          "3e5b7e82-f018-4eaf-ae78-d6145a906b20"
        ],
        "package_ndc": [
          "50242-108-01",
          "50242-108-86",
          "50242-109-01"
        ],
        "nui": [
          "N0000175078",
          "N0000175657",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_moa": [
          "CD20-directed Antibody Interactions [MoA]"
        ],
        "pharm_class_epc": [
          "CD20-directed Cytolytic Antibody [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "4F4X42SYQ6",
          "743QUY4VD8"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "RITUXAN HYCELA",
          "active_ingredients": [
            {
              "name": "RITUXIMAB",
              "strength": "1400MG and 23400UNITS/11.7ML"
            },
            {
              "name": "HYALURONIDASE (HUMAN RECOMBINANT)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "RITUXAN HYCELA",
          "active_ingredients": [
            {
              "name": "RITUXIMAB",
              "strength": "1600MG and 26800UNITS/13.4ML"
            },
            {
              "name": "HYALURONIDASE (HUMAN RECOMBINANT)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}